{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T23:55:17Z","timestamp":1773100517254,"version":"3.50.1"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1097\/inf.0b013e31825d0d67","type":"journal-article","created":{"date-parts":[[2012,5,9]],"date-time":"2012-05-09T08:19:03Z","timestamp":1336551543000},"page":"974-977","source":"Crossref","is-referenced-by-count":22,"title":["Serial T-Spot.TB and Quantiferon-TB-Gold In-Tube Assays to Monitor Response to Antitubercular Treatment in Italian Children With Active or Latent Tuberculosis Infection"],"prefix":"10.1097","volume":"31","author":[{"given":"Elena","family":"Chiappini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Bonsignori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giusi","family":"Mangone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Galli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachele","family":"Mazzantini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Sollai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Azzari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"de Martino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-27-20210202","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1183\/09031936.00151309","article-title":"Tuberculosis treatment effect on T-cell interferon-gamma responses to Mycobacterium tuberculosis-specific antigens.","volume":"36","author":"Chee","year":"2010","journal-title":"Eur Respir J"},{"key":"R2-27-20210202","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1086\/381754","article-title":"Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy.","volume":"38","author":"Carrara","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R3-27-20210202","doi-asserted-by":"crossref","first-page":"e5187","DOI":"10.1371\/journal.pone.0005187","article-title":"In vivoin vitro effects of antituberculosis treatment on mycobacterial interferon-gamma T cell response.","volume":"4","author":"Sauzullo","year":"2009","journal-title":"PLoS ONE"},{"key":"R4-27-20210202","first-page":"30","article-title":"Do results of the T-SPOT.","volume":"103","author":"Bosshard","year":"2009","journal-title":"TB interferon-gamma release assay change after treatment of tuberculosis Respir Med"},{"key":"R5-27-20210202","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.2169\/internalmedicine.47.1313","article-title":"Long-term follow-up of the QuantiFERON TB-2G test for active tuberculosis disease.","volume":"47","author":"Kobashi","year":"2008","journal-title":"Intern Med"},{"key":"R6-27-20210202","doi-asserted-by":"crossref","first-page":"e4130","DOI":"10.1371\/journal.pone.0004130","article-title":"Temporal dynamics of interferon gamma responses in children evaluated for tuberculosis.","volume":"4","author":"Herrmann","year":"2009","journal-title":"PLoS ONE"},{"key":"R7-27-20210202","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/ppul.21555","article-title":"Serial interferon- release assay in children with latent tuberculosis infection and children with tuberculosis.","volume":"47","author":"Nenadic","year":"2012","journal-title":"Pediatr Pulmonol"},{"key":"R8-27-20210202","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1183\/09031936.00153408","article-title":"Interferon-gamma release assays do not identify more children with active tuberculosis than the tuberculin skin test.","volume":"33","author":"Kampmann","year":"2009","journal-title":"Eur Respir J"},{"key":"R10-27-20210202","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2334-9-23","article-title":"T-SPOT.TB responses during treatment of pulmonary tuberculosis.","volume":"9","author":"Ribeiro","year":"2009","journal-title":"BMC Infect Dis"},{"key":"R11-27-20210202","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1471-2334-10-57","article-title":"Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country.","volume":"10","author":"Dyrhol-Riise","year":"2010","journal-title":"BMC Infect Dis"},{"key":"R12-27-20210202","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.rmed.2009.10.006","article-title":"Serial interferon-gamma release assays after rifampicin prophylaxis in a tuberculosis outbreak.","volume":"104","author":"Lee","year":"2010","journal-title":"Respir Med"},{"key":"R13-27-20210202","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/1471-2334-10-300","article-title":"Serial interferon-gamma release assays during treatment of active tuberculosis in young adults.","volume":"10","author":"Lee","year":"2010","journal-title":"BMC Infect Dis"},{"key":"R14-27-20210202","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.rmed.2010.05.011","article-title":"Limited usefulness of QuantiFERON-TB Gold In-Tube for monitoring anti-tuberculosis therapy.","volume":"104","author":"Bocchino","year":"2010","journal-title":"Respir Med"},{"key":"R15-27-20210202","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/INF.0b013e3181609a0a","article-title":"Completion of therapy for latent tuberculosis in children of different nationalities.","volume":"27","author":"Powell","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"R16-27-20210202","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/INF.0b013e318236984f","article-title":"Increasing adherence for latent tuberculosis infection therapy with health department-administered therapy.","volume":"31","author":"Cruz","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"R17-27-20210202","doi-asserted-by":"crossref","first-page":"e1850","DOI":"10.1371\/journal.pone.0001850","article-title":"T-cell assays for tuberculosis infection: deriving cut-offs for conversions using reproducibility data.","volume":"3","author":"Veerapathran","year":"2008","journal-title":"PLoS ONE"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006454-201209000-00027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:02:25Z","timestamp":1618034545000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201209000-00027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":16,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e31825d0d67","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}